Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.12 trillion and total revenue of $110.18 billion.
Market Cap
1.12T
Revenue
110.18B
Profits
-39.61B
PE Ratio
n/a
Profit Margin
-35.95%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.45B | -1.91% | 1,244,716 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.18B | -1.98% | 999,271 | 14.34B |
| 3 | ARGX | argenx SE | 46.37B | 0.49% | 371,962 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.29B | -3.01% | 872,386 | 3.71B |
| 5 | INSM | Insmed Incorporated | 35.01B | -1.47% | 1,808,983 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 34.46B | 0.76% | 133,246 | 5.34B |
| 7 | RPRX | Royalty Pharma plc | 28.02B | 0.16% | 2,724,366 | 2.38B |
| 8 | BNTX | BioNTech SE | 21.88B | 1.97% | 785,603 | 3.37B |
| 9 | ROIV | Roivant Sciences Ltd. | 20.28B | 1.76% | 4,995,623 | 13.31M |
| 10 | RVMD | Revolution Medicines, Inc. | 19.64B | 0.49% | 1,330,907 | - |
| 11 | MRNA | Moderna, Inc. | 19.51B | -1.66% | 4,629,854 | 1.94B |
| 12 | INCY | Incyte Corporation | 19.09B | 1.73% | 1,157,618 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.77B | 1.03% | 1,081,615 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 15.03B | 2.43% | 3,064,703 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.18B | -1.75% | 1,229,767 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.07B | 0.44% | 754,685 | 845.52M |
| 17 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.55B | 3.22% | 344,995 | 958.40M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.35B | -0.45% | 1,791,623 | 943.71M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.51B | -0.70% | 695,760 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.40B | -0.36% | 1,664,634 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.67B | -3.04% | 2,315,853 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.27B | 2.96% | 962,854 | 5.37M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.64B | -2.79% | 292,900 | 7.46M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 8.62B | -1.91% | 616,848 | 638.50M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.55B | -3.00% | 1,445,790 | 1.09B |
| 26 | PCVX | Vaxcyte, Inc. | 8.40B | -0.21% | 1,014,323 | - |
| 27 | TECH | Bio-Techne Corporation | 8.31B | -0.65% | 1,802,099 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.29B | -0.20% | 991,499 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.22B | 0.18% | 2,479,271 | 88.04M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.64B | -1.39% | 1,523,417 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 7.63B | 0.79% | 203,764 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.54B | 2.24% | 14,195,695 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.97B | 0.55% | 690,883 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.73B | 0.02% | 1,211,968 | 22.29M |
| 35 | BLTE | Belite Bio, Inc | 6.68B | 1.33% | 213,953 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.62B | 0.11% | 600,004 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.23B | 0.12% | 676,784 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.43% | 3,646,709 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | -0.13% | 10,851,345 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.89B | -2.08% | 546,140 | 189.76M |
| 41 | SRRK | Scholar Rock Holding Corporation | 5.75B | 1.34% | 2,025,235 | - |
| 42 | CGON | CG Oncology, Inc. | 5.70B | 1.03% | 1,278,710 | 4.04M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.68B | -0.48% | 742,702 | 521.31M |
| 44 | COGT | Cogent Biosciences, Inc. | 5.67B | -0.09% | 1,979,624 | - |
| 45 | PTCT | PTC Therapeutics, Inc. | 5.61B | -1.43% | 482,658 | 1.73B |
| 46 | ERAS | Erasca, Inc. | 5.54B | 7.29% | 5,480,026 | - |
| 47 | CAI | Caris Life Sciences, Inc. | 5.45B | 0.84% | 1,541,480 | 812.03M |
| 48 | CELC | Celcuity Inc. | 5.44B | -0.27% | 501,388 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.43B | 0.28% | 897,202 | 7.50M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.17B | 0.05% | 10,326,900 | 1.00B |
| 51 | IMVT | Immunovant, Inc. | 4.99B | -2.39% | 2,024,993 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 4.95B | -0.15% | 1,531,079 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.75B | 1.43% | 1,727,476 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.55B | 1.70% | 879,699 | 2.04M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 4.53B | - | 2,991,120 | 634.21M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.52B | 1.21% | 1,498,224 | 761.41M |
| 57 | VKTX | Viking Therapeutics, Inc. | 4.02B | 5.58% | 3,599,964 | - |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 3.98B | -0.02% | 221,911 | 268.09M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.90B | 1.80% | 1,247,681 | 7.70M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.79B | 0.55% | 725,189 | 22.50M |
| 61 | GPCR | Structure Therapeutics Inc. | 3.79B | 6.60% | 1,708,381 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | -0.56% | 1,702,426 | 1.07B |
| 63 | SYRE | Spyre Therapeutics, Inc. | 3.74B | -2.70% | 438,009 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.58B | 0.57% | 985,861 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.54B | 0.47% | 1,237,398 | 1.03B |
| 66 | DNLI | Denali Therapeutics Inc. | 3.27B | 4.93% | 1,625,741 | - |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.11B | 4.09% | 1,939,505 | - |
| 68 | TNGX | Tango Therapeutics, Inc. | 3.09B | 1.93% | 2,923,246 | 62.38M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.03B | -1.19% | 169,892 | 803.79M |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.02B | -0.52% | 616,161 | 588.99M |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.98B | -0.14% | 370,831 | 451.36M |
| 72 | ALMS | Alumis Inc. | 2.97B | 2.82% | 1,412,363 | 24.05M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.93B | -1.95% | 1,090,531 | 376.07M |
| 74 | VERA | Vera Therapeutics, Inc. | 2.92B | 0.89% | 706,027 | - |
| 75 | RCUS | Arcus Biosciences, Inc. | 2.88B | 5.13% | 1,576,105 | 247.00M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.88B | 0.80% | 694,022 | 218.71M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.81B | -3.12% | 1,147,835 | 490.73M |
| 78 | ORKA | Oruka Therapeutics, Inc. | 2.64B | 5.71% | 1,635,820 | - |
| 79 | KOD | Kodiak Sciences Inc. | 2.51B | -5.09% | 1,690,003 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.49B | 0.62% | 570,029 | - |
| 81 | IMNM | Immunome, Inc. | 2.47B | -2.72% | 1,602,338 | 6.94M |
| 82 | BEAM | Beam Therapeutics Inc. | 2.45B | 1.82% | 1,853,344 | 139.74M |
| 83 | AAPG | Ascentage Pharma Group International | 2.44B | 3.96% | 6,548 | 82.08M |
| 84 | SRPT | Sarepta Therapeutics, Inc. | 2.44B | 4.97% | 3,157,106 | 2.20B |
| 85 | MANE | Veradermics, Incorporated | 2.40B | 9.20% | 839,633 | - |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.32B | 2.75% | 810,852 | - |
| 87 | ZLAB | Zai Lab Limited | 2.30B | 0.34% | 707,426 | 460.16M |
| 88 | ADPT | Adaptive Biotechnologies Corporation | 2.28B | 2.63% | 1,565,135 | 276.98M |
| 89 | RLAY | Relay Therapeutics, Inc. | 2.24B | 16.43% | 8,886,762 | 15.36M |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.22B | 2.12% | 1,645,136 | - |
| 91 | SNDX | Syndax Pharmaceuticals, Inc. | 2.22B | 5.32% | 2,092,876 | 172.35M |
| 92 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.14% | 1,403,638 | 158.18M |
| 93 | NKTR | Nektar Therapeutics | 2.21B | 1.69% | 552,798 | 55.23M |
| 94 | RARE | Ultragenyx Pharmaceutical Inc. | 2.20B | 4.81% | 1,770,395 | 673.00M |
| 95 | ADMA | ADMA Biologics, Inc. | 2.19B | 0.88% | 6,126,384 | 510.17M |
| 96 | TYRA | Tyra Biosciences, Inc. | 2.13B | 3.47% | 1,048,108 | - |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.08B | 0.90% | 1,259,953 | 283.06M |
| 98 | CLDX | Celldex Therapeutics, Inc. | 2.07B | -0.64% | 5,167,183 | 1.55M |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 2.06B | 2.95% | 1,425,392 | 54.03M |
| 100 | DFTX | Definium Therapeutics, Inc. | 2.06B | 0.39% | 1,957,745 | - |
| 101 | SLNO | Soleno Therapeutics, Inc. | 2.04B | 6.76% | 3,571,060 | 190.41M |
| 102 | GLPG | Galapagos NV | 1.95B | -1.14% | 176,232 | 1.31B |
| 103 | STOK | Stoke Therapeutics, Inc. | 1.94B | 2.34% | 564,255 | 184.42M |
| 104 | VRDN | Viridian Therapeutics, Inc. | 1.93B | -1.62% | 3,056,074 | 70.85M |
| 105 | ZYME | Zymeworks Inc. | 1.90B | -0.54% | 701,734 | 105.97M |
| 106 | MESO | Mesoblast Limited | 1.90B | -6.27% | 172,614 | 65.38M |
| 107 | PHVS | Pharvaris N.V. | 1.86B | -3.53% | 243,617 | - |
| 108 | OCUL | Ocular Therapeutix, Inc. | 1.85B | 1.92% | 4,372,204 | 51.95M |
| 109 | CAPR | Capricor Therapeutics, Inc. | 1.85B | 6.61% | 1,225,529 | 11.13M |
| 110 | SION | Sionna Therapeutics, Inc. | 1.82B | -1.96% | 525,211 | - |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.77B | 2.56% | 333,943 | - |
| 112 | GENB | Generate Biomedicines, Inc. | 1.75B | 3.31% | 460,786 | 31.89M |
| 113 | VCEL | Vericel Corporation | 1.74B | 4.85% | 1,685,760 | 276.26M |
| 114 | INVA | Innoviva, Inc. | 1.70B | -1.79% | 595,045 | 411.33M |
| 115 | ANAB | AnaptysBio, Inc. | 1.66B | 1.67% | 611,617 | 234.60M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.64B | 1.63% | 9,240,119 | 74.68M |
| 117 | RAPP | Rapport Therapeutics, Inc. | 1.61B | 6.03% | 218,319 | - |
| 118 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -0.79% | 523,806 | 868.45M |
| 119 | NRIX | Nurix Therapeutics, Inc. | 1.60B | 0.19% | 1,165,288 | 83.98M |
| 120 | OCS | Oculis Holding AG | 1.58B | -1.74% | 109,784 | 1.51M |
| 121 | MBX | MBX Biosciences, Inc. | 1.57B | 2.17% | 601,665 | - |
| 122 | IMCR | Immunocore Holdings plc | 1.56B | 1.72% | 477,439 | 400.02M |
| 123 | NTLA | Intellia Therapeutics, Inc. | 1.55B | -1.06% | 2,742,329 | 67.67M |
| 124 | NBTX | Nanobiotix S.A. | 1.53B | -8.89% | 98,529 | 38.27M |
| 125 | TRVI | Trevi Therapeutics, Inc. | 1.53B | 3.11% | 1,218,879 | - |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.51B | 0.04% | 237,721 | - |
| 127 | NUVB | Nuvation Bio Inc. | 1.51B | -2.22% | 2,413,692 | 62.90M |
| 128 | BHVN | Biohaven Ltd. | 1.47B | 1.87% | 2,600,006 | - |
| 129 | ARDX | Ardelyx, Inc. | 1.46B | -2.78% | 2,398,250 | 407.32M |
| 130 | VIR | Vir Biotechnology, Inc. | 1.45B | 0.44% | 1,727,183 | 68.56M |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.43B | -1.17% | 780,214 | 2.50M |
| 132 | IOVA | Iovance Biotherapeutics, Inc. | 1.41B | -0.58% | 7,787,718 | 263.50M |
| 133 | SVRA | Savara Inc. | 1.41B | -0.36% | 811,618 | - |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.41B | 4.73% | 919,280 | - |
| 135 | PGEN | Precigen, Inc. | 1.39B | 0.25% | 5,443,232 | 9.68M |
| 136 | IMTX | Immatics N.V. | 1.39B | 3.40% | 439,808 | 56.67M |
| 137 | ATAI | AtaiBeckley Inc. | 1.38B | 2.43% | 3,053,400 | 4.09M |
| 138 | WVE | Wave Life Sciences Ltd. | 1.37B | 6.59% | 4,068,293 | 42.73M |
| 139 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | -0.47% | 1,240,310 | 123.67M |
| 140 | OLMA | Olema Pharmaceuticals, Inc. | 1.31B | -0.40% | 904,319 | - |
| 141 | ZBIO | Zenas BioPharma, Inc. | 1.28B | 5.40% | 1,722,544 | 10.00M |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | 1.39% | 1,580,662 | 9.77M |
| 143 | NVAX | Novavax, Inc. | 1.25B | -3.99% | 4,650,901 | 1.12B |
| 144 | MLTX | MoonLake Immunotherapeutics | 1.25B | 5.08% | 1,686,296 | - |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | 1.80% | 660,469 | - |
| 146 | DBVT | DBV Technologies S.A. | 1.17B | 2.63% | 446,575 | 5.64M |
| 147 | PHAR | Pharming Group N.V. | 1.16B | -4.91% | 41,581 | 376.13M |
| 148 | SEPN | Septerna, Inc. | 1.13B | 3.32% | 287,816 | 45.95M |
| 149 | EYPT | EyePoint, Inc. | 1.12B | 2.92% | 1,154,737 | 31.37M |
| 150 | AVBP | ArriVent BioPharma, Inc. | 1.10B | 2.77% | 362,884 | - |
| 151 | QURE | uniQure N.V. | 1.07B | 1.60% | 1,192,646 | 16.10M |
| 152 | ABCL | AbCellera Biologics Inc. | 1.07B | 0.28% | 3,489,508 | 75.13M |
| 153 | GERN | Geron Corporation | 1.06B | - | 33,580,702 | 183.88M |
| 154 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | - | 1,337,692 | 291.85M |
| 155 | IVA | Inventiva S.A. | 1.04B | 0.74% | 321,489 | 9.31M |
| 156 | KALV | KalVista Pharmaceuticals, Inc. | 1.02B | 0.66% | 910,079 | 73.62M |
| 157 | CTMX | CytomX Therapeutics, Inc. | 985.77M | - | 4,718,172 | 76.20M |
| 158 | CMPX | Compass Therapeutics, Inc. | 981.48M | 0.37% | 3,183,387 | 850.00K |
| 159 | VOR | Vor Biopharma Inc. | 978.05M | 3.80% | 1,524,843 | - |
| 160 | AKTS | Aktis Oncology, Inc. | 960.14M | 1.76% | 384,686 | 6.50M |
| 161 | XNCR | Xencor, Inc. | 939.47M | 2.23% | 608,504 | 125.58M |
| 162 | MPLT | MapLight Therapeutics, Inc. | 931.99M | 1.63% | 146,587 | - |
| 163 | INBX | Inhibrx Biosciences, Inc. | 927.98M | -5.25% | 190,000 | 1.30M |
| 164 | URGN | UroGen Pharma Ltd. | 916.20M | -0.63% | 381,800 | 109.79M |
| 165 | GHRS | GH Research PLC | 903.77M | -1.02% | 102,674 | - |
| 166 | JANX | Janux Therapeutics, Inc. | 902.74M | 2.27% | 1,304,860 | 10.00M |
| 167 | PHAT | Phathom Pharmaceuticals, Inc. | 893.58M | 1.80% | 785,117 | 175.11M |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 892.18M | 18.85% | 7,285,489 | - |
| 169 | FTRE | Fortrea Holdings Inc. | 883.58M | -0.79% | 845,294 | 2.72B |
| 170 | ANNX | Annexon, Inc. | 882.61M | 2.61% | 3,331,277 | - |
| 171 | ABUS | Arbutus Biopharma Corporation | 875.74M | -0.88% | 612,121 | 14.08M |
| 172 | CGEM | Cullinan Therapeutics, Inc. | 873.39M | 3.52% | 1,149,537 | - |
| 173 | EVMN | Evommune, Inc. | 854.36M | 5.80% | 380,635 | 13.00M |
| 174 | SANA | Sana Biotechnology, Inc. | 853.97M | 4.92% | 3,282,182 | - |
| 175 | TBPH | Theravance Biopharma, Inc. | 824.92M | 1.14% | 508,727 | 107.46M |
| 176 | SPRY | ARS Pharmaceuticals, Inc. | 824.17M | 2.34% | 1,274,391 | 84.28M |
| 177 | OMER | Omeros Corporation | 784.76M | -9.77% | 1,837,286 | - |
| 178 | MNKD | MannKind Corporation | 770.25M | -1.57% | 3,757,362 | 348.97M |
| 179 | JBIO | Jade Biosciences, Inc. | 763.91M | -3.31% | 402,826 | - |
| 180 | KURA | Kura Oncology, Inc. | 760.52M | 3.24% | 4,391,099 | 67.48M |
| 181 | MRVI | Maravai LifeSciences Holdings, Inc. | 758.35M | 2.79% | 1,751,526 | 185.74M |
| 182 | TENX | Tenax Therapeutics, Inc. | 755.26M | -6.16% | 333,708 | - |
| 183 | SGP | SpyGlass Pharma, Inc. | 750.76M | -8.10% | 130,657 | - |
| 184 | MGTX | MeiraGTx Holdings plc | 747.68M | 0.99% | 1,094,403 | 81.39M |
| 185 | SLS | SELLAS Life Sciences Group, Inc. | 741.68M | -1.90% | 4,862,807 | - |
| 186 | SLDB | Solid Biosciences Inc. | 736.95M | 1.49% | 808,422 | - |
| 187 | RLMD | Relmada Therapeutics, Inc. | 733.18M | -1.55% | 1,844,566 | - |
| 188 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 713.09M | -1.33% | 164,842 | - |
| 189 | REPL | Replimune Group, Inc. | 694.44M | 10.51% | 3,182,698 | - |
| 190 | ARVN | Arvinas, Inc. | 693.98M | -4.24% | 1,289,307 | 262.60M |
| 191 | DSGN | Design Therapeutics, Inc. | 692.58M | 2.00% | 314,296 | - |
| 192 | ANRO | Alto Neuroscience, Inc. | 692.58M | -7.39% | 710,509 | - |
| 193 | DRUG | Bright Minds Biosciences Inc. | 689.00M | -0.36% | 188,443 | - |
| 194 | LXRX | Lexicon Pharmaceuticals, Inc. | 673.65M | -3.05% | 2,315,942 | 49.80M |
| 195 | GYRE | Gyre Therapeutics, Inc. | 650.16M | -1.52% | 63,440 | 116.59M |
| 196 | LBRX | LB Pharmaceuticals Inc | 649.93M | 3.55% | 342,089 | - |
| 197 | CBIO | Crescent Biopharma, Inc. | 644.35M | 0.41% | 209,004 | 10.84M |
| 198 | DRTS | Alpha Tau Medical Ltd. | 609.03M | - | 168,379 | - |
| 199 | OCGN | Ocugen, Inc. | 604.84M | - | 5,015,984 | 4.41M |
| 200 | ALLO | Allogene Therapeutics, Inc. | 604.57M | -3.13% | 4,328,903 | 22.00K |
| 201 | PRME | Prime Medicine, Inc. | 587.90M | -2.06% | 1,641,419 | 4.63M |
| 202 | ACRS | Aclaris Therapeutics, Inc. | 583.78M | 1.45% | 937,456 | 7.83M |
| 203 | MDXG | MiMedx Group, Inc. | 582.38M | -0.76% | 1,678,547 | 418.63M |
| 204 | PROK | ProKidney Corp. | 573.64M | 8.57% | 1,052,860 | 893.00K |
| 205 | TECX | Tectonic Therapeutic, Inc. | 573.06M | -0.84% | 163,002 | - |
| 206 | ZURA | Zura Bio Limited | 572.13M | - | 444,928 | - |
| 207 | CRMD | CorMedix Inc. | 557.31M | 0.43% | 1,671,199 | 311.71M |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 551.89M | -0.11% | 587,127 | 106.47M |
| 209 | VALN | Valneva SE | 543.61M | -2.71% | 248,378 | 205.07M |
| 210 | KYTX | Kyverna Therapeutics, Inc. | 536.24M | 1.14% | 757,061 | - |
| 211 | EIKN | Eikon Therapeutics, Inc. | 535.97M | -1.79% | 252,604 | - |
| 212 | FULC | Fulcrum Therapeutics, Inc. | 535.47M | 7.49% | 1,012,328 | 80.00M |
| 213 | PRTA | Prothena Corporation plc | 530.79M | -1.69% | 848,132 | 9.68M |
| 214 | YDES | YD Bio Limited | 522.48M | 1.92% | 8,824 | 510.36K |
| 215 | AGMB | AgomAb Therapeutics NV | 522.46M | -9.00% | 185,408 | - |
| 216 | UPB | Upstream Bio, Inc. | 516.99M | 2.04% | 537,596 | 2.85M |
| 217 | VTVT | vTv Therapeutics Inc. | 510.90M | 1.58% | 40,992 | 17.00K |
| 218 | RIGL | Rigel Pharmaceuticals, Inc. | 508.57M | 0.11% | 185,754 | 294.28M |
| 219 | CTNM | Contineum Therapeutics, Inc. | 501.80M | -0.07% | 111,074 | - |
| 220 | LRMR | Larimar Therapeutics, Inc. | 497.60M | 2.35% | 993,134 | - |
| 221 | VSTM | Verastem, Inc. | 494.51M | 1.44% | 1,837,540 | 30.91M |
| 222 | LYEL | Lyell Immunopharma, Inc. | 494.34M | 1.92% | 88,851 | 36.00K |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 483.97M | -3.95% | 706,895 | 85.21M |
| 224 | ADCT | ADC Therapeutics SA | 480.23M | -0.53% | 1,355,063 | 81.36M |
| 225 | IMMX | Immix Biopharma, Inc. | 473.50M | 3.71% | 418,130 | - |
| 226 | TRDA | Entrada Therapeutics, Inc. | 473.40M | -2.45% | 178,007 | 25.42M |
| 227 | ABSI | Absci Corporation | 468.25M | -2.86% | 4,674,933 | 2.80M |
| 228 | ASMB | Assembly Biosciences, Inc. | 460.18M | -1.16% | 37,856 | 72.30M |
| 229 | STTK | Shattuck Labs, Inc. | 459.44M | 2.72% | 442,619 | 1.00M |
| 230 | AVIR | Atea Pharmaceuticals, Inc. | 458.91M | 1.95% | 442,794 | - |
| 231 | FBRX | Forte Biosciences, Inc. | 456.13M | 2.90% | 241,599 | - |
| 232 | ENGN | enGene Holdings Inc. | 448.16M | -1.04% | 332,758 | - |
| 233 | RGNX | REGENXBIO Inc. | 440.26M | -1.16% | 420,546 | 170.44M |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 439.78M | -2.18% | 259,611 | - |
| 235 | ALT | Altimmune, Inc. | 434.55M | 7.05% | 2,737,031 | 41.00K |
| 236 | LXEO | Lexeo Therapeutics, Inc. | 423.78M | 0.88% | 625,724 | - |
| 237 | AURA | Aura Biosciences, Inc. | 419.54M | -2.39% | 175,740 | - |
| 238 | NAUT | Nautilus Biotechnology, Inc. | 418.30M | -1.49% | 217,138 | - |
| 239 | VNDA | Vanda Pharmaceuticals Inc. | 413.76M | -0.99% | 919,732 | 216.11M |
| 240 | AVTX | Avalo Therapeutics, Inc. | 404.72M | 6.35% | 1,109,141 | 59.00K |
| 241 | DNA | Ginkgo Bioworks Holdings, Inc. | 401.63M | 1.62% | 1,438,216 | 170.16M |
| 242 | STRO | Sutro Biopharma, Inc. | 393.97M | -4.38% | 126,543 | 102.48M |
| 243 | XOMA | XOMA Royalty Corporation | 392.98M | -0.30% | 93,533 | 52.15M |
| 244 | LCTX | Lineage Cell Therapeutics, Inc. | 391.07M | -1.26% | 581,885 | 14.56M |
| 245 | XFOR | X4 Pharmaceuticals, Inc. | 385.50M | -2.53% | 205,887 | 35.11M |
| 246 | RCKT | Rocket Pharmaceuticals, Inc. | 385.42M | -1.93% | 2,278,151 | - |
| 247 | IPSC | Century Therapeutics, Inc. | 382.81M | -2.74% | 678,110 | 109.16M |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 381.31M | 1.31% | 112,823 | 66.98M |
| 249 | AUTL | Autolus Therapeutics plc | 375.26M | 2.17% | 1,030,849 | 75.39M |
| 250 | BNTC | Benitec Biopharma Inc. | 374.06M | -0.46% | 53,609 | - |
| 251 | ARMP | Armata Pharmaceuticals, Inc. | 372.92M | -3.60% | 22,947 | 4.90M |
| 252 | MNPR | Monopar Therapeutics Inc. | 368.41M | -0.47% | 145,049 | - |
| 253 | CADL | Candel Therapeutics, Inc. | 366.23M | 0.40% | 910,354 | - |
| 254 | PRTC | PureTech Health plc | 364.17M | 3.40% | 12,349 | 6.39M |
| 255 | NMRA | Neumora Therapeutics, Inc. | 364.08M | -4.31% | 1,238,189 | - |
| 256 | IVVD | Invivyd, Inc. | 361.72M | -3.76% | 3,902,674 | 53.43M |
| 257 | IMRX | Immuneering Corporation | 352.36M | 2.25% | 597,272 | - |
| 258 | BCYC | Bicycle Therapeutics plc | 352.02M | 3.06% | 324,994 | 72.59M |
| 259 | NAGE | Niagen Bioscience, Inc. | 351.48M | -3.10% | 752,444 | 129.42M |
| 260 | PBYI | Puma Biotechnology, Inc. | 351.05M | 2.07% | 347,375 | 228.37M |
| 261 | DMAC | DiaMedica Therapeutics Inc. | 349.16M | 0.93% | 131,416 | - |
| 262 | NGEN | NervGen Pharma Corp. | 339.31M | -2.29% | 611,791 | - |
| 263 | PLYX | Polaryx Therapeutics, Inc. | 338.03M | -6.05% | 251,695 | - |
| 264 | CABA | Cabaletta Bio, Inc. | 329.52M | 10.45% | 2,106,717 | - |
| 265 | RZLT | Rezolute, Inc. | 324.08M | -0.32% | 684,817 | - |
| 266 | IRD | Opus Genetics, Inc. | 323.73M | -2.99% | 348,119 | 14.20M |
| 267 | NGNE | Neurogene Inc. | 322.23M | -4.48% | 182,425 | 925.00K |
| 268 | SRZN | Surrozen, Inc. | 320.13M | -2.00% | 35,912 | 3.48M |
| 269 | GLSI | Greenwich LifeSciences, Inc. | 316.16M | -0.61% | 54,539 | - |
| 270 | PALI | Palisade Bio, Inc. | 313.52M | 0.53% | 2,540,218 | - |
| 271 | CLYM | Climb Bio, Inc. | 313.36M | -5.61% | 441,295 | - |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 306.76M | -0.55% | 759,855 | 1.00 |
| 273 | LENZ | LENZ Therapeutics, Inc. | 303.20M | 3.42% | 697,917 | 19.09M |
| 274 | ANL | Adlai Nortye Ltd. | 301.84M | 3.54% | 454,601 | -1.35M |
| 275 | OVID | Ovid Therapeutics Inc. | 290.12M | 1.85% | 1,401,874 | 7.25M |
| 276 | FHTX | Foghorn Therapeutics Inc. | 289.39M | 0.61% | 87,657 | 30.91M |
| 277 | PRLD | Prelude Therapeutics Incorporated | 285.57M | 0.29% | 105,677 | 12.14M |
| 278 | SLN | Silence Therapeutics plc | 280.57M | 8.59% | 285,402 | 559.00K |
| 279 | NBP | NovaBridge Biosciences | 280.16M | -1.22% | 1,524,551 | - |
| 280 | AVXL | Anavex Life Sciences Corp. | 277.09M | -3.55% | 1,154,700 | - |
| 281 | TARA | Protara Therapeutics, Inc. | 276.37M | 1.39% | 511,473 | - |
| 282 | CCCC | C4 Therapeutics, Inc. | 275.17M | 4.44% | 2,127,265 | 35.95M |
| 283 | ABEO | Abeona Therapeutics Inc. | 274.98M | 5.24% | 761,924 | 5.82M |
| 284 | ACIU | AC Immune SA | 273.80M | -1.08% | 119,799 | 4.51M |
| 285 | SABS | SAB Biotherapeutics, Inc. | 272.67M | 0.26% | 204,738 | 114.70K |
| 286 | ALEC | Alector, Inc. | 265.97M | -4.74% | 1,316,515 | 21.05M |
| 287 | EDIT | Editas Medicine, Inc. | 261.32M | 2.30% | 1,125,209 | 40.52M |
| 288 | CLLS | Cellectis S.A. | 260.21M | 0.89% | 28,661 | 79.59M |
| 289 | SLGL | Sol-Gel Technologies Ltd. | 259.75M | -4.84% | 80,092 | 19.39M |
| 290 | CHRS | Coherus Oncology, Inc. | 259.31M | -0.57% | 537,231 | 42.17M |
| 291 | ALXO | ALX Oncology Holdings Inc. | 259.27M | -0.51% | 415,129 | - |
| 292 | HELP | Cybin Inc. | 256.18M | 2.61% | 892,675 | - |
| 293 | CNTX | Context Therapeutics Inc. | 249.91M | 2.64% | 1,100,116 | - |
| 294 | OBIO | Orchestra BioMed Holdings, Inc. | 249.88M | -1.61% | 139,311 | 33.48M |
| 295 | KROS | Keros Therapeutics, Inc. | 236.61M | 2.65% | 558,247 | 244.06M |
| 296 | VYGR | Voyager Therapeutics, Inc. | 236.01M | -0.75% | 462,505 | 40.37M |
| 297 | ELDN | Eledon Pharmaceuticals, Inc. | 233.22M | 2.33% | 1,187,842 | - |
| 298 | CAMP | Camp4 Therapeutics Corporation | 232.08M | 0.22% | 38,012 | 3.50M |
| 299 | NERV | Minerva Neurosciences, Inc. | 228.49M | -5.71% | 188,598 | - |
| 300 | ARCT | Arcturus Therapeutics Holdings Inc. | 228.24M | 2.29% | 503,297 | 82.03M |
| 301 | ENLV | Enlivex Ltd. | 225.99M | -1.07% | 307,478 | - |
| 302 | OABI | OmniAb, Inc. | 222.97M | -1.28% | 273,492 | 18.67M |
| 303 | FENC | Fennec Pharmaceuticals Inc. | 221.33M | 0.16% | 267,076 | 44.64M |
| 304 | MDWD | MediWound Ltd. | 216.05M | 3.77% | 299,646 | 16.96M |
| 305 | CGEN | Compugen Ltd. | 213.69M | 2.73% | 205,711 | 72.76M |
| 306 | KRRO | Korro Bio, Inc. | 201.92M | 10.67% | 303,355 | 6.39M |
| 307 | NVCT | Nuvectis Pharma, Inc. | 200.28M | -0.53% | 18,249 | - |
| 308 | TNXP | Tonix Pharmaceuticals Holding Corp. | 197.46M | 1.61% | 313,746 | 13.11M |
| 309 | ELTX | Elicio Therapeutics, Inc. | 195.92M | -0.61% | 69,297 | - |
| 310 | MGNX | MacroGenics, Inc. | 195.12M | 5.86% | 713,102 | 149.50M |
| 311 | ABOS | Acumen Pharmaceuticals, Inc. | 194.97M | 5.88% | 635,597 | - |
| 312 | MENS | Jyong Biotech Ltd. | 188.41M | 7.46% | 174,558 | - |
| 313 | ADAG | Adagene Inc. | 188.05M | -13.45% | 1,225,524 | 7.67M |
| 314 | CRBU | Caribou Biosciences, Inc. | 187.48M | -2.51% | 1,063,879 | 11.16M |
| 315 | ZNTL | Zentalis Pharmaceuticals, Inc. | 186.55M | 2.33% | 357,776 | 26.87M |
| 316 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 180.38M | 1.90% | 236,352 | - |
| 317 | PRQR | ProQR Therapeutics N.V. | 180.17M | - | 240,600 | 19.19M |
| 318 | GALT | Galectin Therapeutics Inc. | 175.76M | -0.37% | 242,649 | - |
| 319 | UNCY | Unicycive Therapeutics, Inc. | 174.90M | -2.67% | 491,099 | - |
| 320 | SGMT | Sagimet Biosciences Inc. | 173.35M | 1.53% | 159,979 | - |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 173.23M | -1.83% | 1,100,329 | 52.74M |
| 322 | ACHV | Achieve Life Sciences, Inc. | 171.97M | 2.87% | 504,863 | - |
| 323 | MIST | Milestone Pharmaceuticals Inc. | 169.26M | 5.34% | 2,087,776 | 1.55M |
| 324 | CNTB | Connect Biopharma Holdings Limited | 169.00M | 9.93% | 859,167 | 64.00K |
| 325 | CNTN | Canton Strategic Holdings, Inc. | 167.95M | 0.62% | 394,808 | - |
| 326 | ARTV | Artiva Biotherapeutics, Inc. | 166.59M | -0.15% | 145,889 | 251.00K |
| 327 | RNAC | Cartesian Therapeutics, Inc. | 165.95M | -2.03% | 60,427 | 2.80M |
| 328 | WHWK | Whitehawk Therapeutics, Inc. | 165.66M | -0.85% | 94,900 | 7.15M |
| 329 | NKTX | Nkarta, Inc. | 165.39M | 5.94% | 449,788 | - |
| 330 | CDXS | Codexis, Inc. | 165.38M | 4.60% | 785,610 | 70.39M |
| 331 | TLSA | Tiziana Life Sciences Ltd | 159.53M | - | 111,083 | - |
| 332 | IMUX | Immunic, Inc. | 151.34M | 0.87% | 808,592 | - |
| 333 | MOLN | Molecular Partners AG | 151.17M | -3.87% | 3,272 | 856.30K |
| 334 | CBUS | Cibus, Inc. | 150.82M | 2.59% | 374,985 | 3.64M |
| 335 | TNYA | Tenaya Therapeutics, Inc. | 150.73M | 2.00% | 1,506,920 | - |
| 336 | HRTX | Heron Therapeutics, Inc. | 150.68M | -0.54% | 913,779 | 154.90M |
| 337 | DTIL | Precision BioSciences, Inc. | 150.17M | 2.28% | 303,809 | 34.26M |
| 338 | HUMA | Humacyte, Inc. | 142.63M | 8.53% | 4,819,977 | 2.04M |
| 339 | FATE | Fate Therapeutics, Inc. | 141.84M | -1.61% | 660,523 | 6.65M |
| 340 | NTHI | NeOnc Technologies Holdings, Inc. | 141.65M | -2.30% | 98,705 | 39.99K |
| 341 | SPRO | Spero Therapeutics, Inc. | 140.68M | -0.82% | 214,354 | 66.80M |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 138.33M | 1.18% | 42,941 | 2.00M |
| 343 | BDTX | Black Diamond Therapeutics, Inc. | 136.92M | 2.58% | 535,378 | 70.00M |
| 344 | KPTI | Karyopharm Therapeutics Inc. | 132.78M | 1.20% | 184,180 | 146.07M |
| 345 | KLRS | Kalaris Therapeutics, Inc. | 132.75M | -1.18% | 23,572 | - |
| 346 | ACOG | Alpha Cognition Inc. | 130.02M | 0.50% | 56,401 | 10.22M |
| 347 | AGEN | Agenus Inc. | 127.87M | -1.76% | 480,746 | 114.20M |
| 348 | IPHA | Innate Pharma S.A. | 125.73M | 2.96% | 17,209 | 10.57M |
| 349 | EQ | Equillium, Inc. | 124.56M | -3.43% | 135,408 | 4.39M |
| 350 | SGMO | Sangamo Therapeutics, Inc. | 124.32M | 15.38% | 8,750,874 | 39.55M |
| 351 | PEPG | PepGen Inc. | 119.57M | -0.57% | 1,716,339 | - |
| 352 | ANTX | AN2 Therapeutics, Inc. | 117.53M | -5.22% | 412,046 | - |
| 353 | GNLX | Genelux Corporation | 114.04M | 0.39% | 138,299 | 8.00K |
| 354 | PMN | ProMIS Neurosciences, Inc. | 112.19M | -3.77% | 32,517 | - |
| 355 | BMEA | Biomea Fusion, Inc. | 111.34M | 3.36% | 1,181,281 | - |
| 356 | CRDF | Cardiff Oncology, Inc. | 108.02M | -1.86% | 528,443 | 593.00K |
| 357 | LONA | LeonaBio, Inc. | 105.96M | 13.27% | 56,488 | - |
| 358 | ONCY | Oncolytics Biotech Inc. | 103.33M | 3.25% | 640,400 | - |
| 359 | ALDX | Aldeyra Therapeutics, Inc. | 99.90M | -1.19% | 1,820,384 | - |
| 360 | TTRX | Turn Therapeutics Inc. | 98.64M | 7.54% | 38,168 | - |
| 361 | SPRB | Spruce Biosciences, Inc. | 96.72M | 1.39% | 37,314 | 697.00K |
| 362 | SEER | Seer, Inc. | 95.92M | 0.29% | 61,819 | 16.58M |
| 363 | COYA | Coya Therapeutics, Inc. | 94.06M | -1.72% | 76,016 | 7.95M |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 93.97M | -0.36% | 38,647 | 35.58M |
| 365 | AARD | Aardvark Therapeutics, Inc. | 93.81M | 5.13% | 134,732 | - |
| 366 | QTTB | Q32 Bio Inc. | 93.34M | 4.42% | 166,634 | 53.74M |
| 367 | PYXS | Pyxis Oncology, Inc. | 92.99M | 0.68% | 194,599 | 13.86M |
| 368 | VANI | Vivani Medical, Inc. | 91.42M | 8.00% | 147,815 | - |
| 369 | HURA | TuHURA Biosciences, Inc. | 89.65M | -12.96% | 1,210,815 | - |
| 370 | MCRB | Seres Therapeutics, Inc. | 88.86M | 4.63% | 76,879 | 789.00K |
| 371 | OKYO | OKYO Pharma Limited | 88.17M | 1.20% | 71,788 | - |
| 372 | GOSS | Gossamer Bio, Inc. | 86.84M | 1.37% | 5,767,202 | 48.47M |
| 373 | ANIX | Anixa Biosciences, Inc. | 85.50M | -6.25% | 69,894 | - |
| 374 | KZIA | Kazia Therapeutics Limited | 83.87M | 2.23% | 28,456 | 1.27M |
| 375 | PYPD | PolyPid Ltd. | 83.78M | - | 54,258 | - |
| 376 | RANI | Rani Therapeutics Holdings, Inc. | 83.75M | 4.27% | 1,062,857 | 1.63M |
| 377 | PLRX | Pliant Therapeutics, Inc. | 83.58M | 2.27% | 521,414 | - |
| 378 | FLNA | Filana Therapeutics, Inc. | 83.57M | 0.58% | 302,729 | - |
| 379 | ATYR | aTyr Pharma, Inc. | 83.04M | -0.46% | 704,051 | 190.00K |
| 380 | NRXS | NeurAxis, Inc. | 81.11M | 0.97% | 44,032 | 3.57M |
| 381 | FBIO | Fortress Biotech, Inc. | 80.70M | 5.26% | 522,462 | 63.26M |
| 382 | MAIA | MAIA Biotechnology, Inc. | 80.69M | -0.75% | 271,311 | - |
| 383 | CSBR | Champions Oncology, Inc. | 80.13M | -2.53% | 2,911 | 57.95M |
| 384 | GRCE | Grace Therapeutics, Inc. | 79.38M | 5.12% | 670,345 | - |
| 385 | GANX | Gain Therapeutics, Inc. | 78.15M | -4.64% | 522,939 | - |
| 386 | INO | Inovio Pharmaceuticals, Inc. | 78.07M | -35.06% | 19,932,756 | 65.34K |
| 387 | CGTX | Cognition Therapeutics, Inc. | 77.56M | -2.63% | 1,048,983 | - |
| 388 | ACET | Adicet Bio, Inc. | 75.14M | 1.45% | 63,856 | - |
| 389 | COEP | Coeptis Therapeutics Holdings, Inc. | 74.55M | 6.21% | 17,405 | 1.36M |
| 390 | EXOZ | eXoZymes, Inc. | 73.42M | 3.55% | 3,660 | -700.00 |
| 391 | NRXP | NRx Pharmaceuticals, Inc. | 72.68M | 1.85% | 355,758 | 1.23M |
| 392 | GUTS | Fractyl Health, Inc. | 72.33M | -1.89% | 1,504,373 | 3.00K |
| 393 | XBIT | XBiotech Inc. | 71.65M | 0.43% | 6,414 | - |
| 394 | PMVP | PMV Pharmaceuticals, Inc. | 71.46M | 0.75% | 99,870 | - |
| 395 | CING | Cingulate Inc. | 71.40M | 2.16% | 330,335 | - |
| 396 | BYSI | BeyondSpring Inc. | 70.93M | 0.88% | 2,351 | 1.88M |
| 397 | MNOV | MediciNova, Inc. | 70.88M | 1.41% | 36,670 | 409.66K |
| 398 | DWTX | Dogwood Therapeutics, Inc. | 70.48M | -0.94% | 18,847 | - |
| 399 | PTHS | Pelthos Therapeutics Inc. | 68.45M | -4.23% | 10,038 | 16.80M |
| 400 | IBIO | iBio, Inc. | 68.40M | 1.54% | 320,580 | 300.00K |
| 401 | ATHE | Alterity Therapeutics Limited | 67.60M | -2.22% | 2,896 | 4.43M |
| 402 | IFRX | InflaRx N.V. | 65.96M | 1.93% | 265,363 | 34.44K |
| 403 | ANVS | Annovis Bio, Inc. | 64.65M | 7.55% | 962,623 | - |
| 404 | IBO | Impact BioMedical Inc. | 63.68M | -3.78% | 44,063 | 32.00K |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 58.89M | 4.11% | 389,065 | - |
| 406 | ACTU | Actuate Therapeutics, Inc. | 58.80M | -0.40% | 59,684 | - |
| 407 | ENTX | Entera Bio Ltd. | 58.74M | 10.53% | 742,504 | 42.00K |
| 408 | OKUR | OnKure Therapeutics, Inc. | 58.66M | 5.41% | 341,923 | - |
| 409 | ICCC | ImmuCell Corporation | 58.26M | 1.42% | 6,897 | 27.64M |
| 410 | TCRX | TScan Therapeutics, Inc. | 57.47M | -1.94% | 666,117 | 10.33M |
| 411 | HYFT | MindWalk Holdings Corp. | 56.62M | 1.32% | 154,975 | 20.70M |
| 412 | IMA | ImageneBio, Inc. | 55.59M | -0.99% | 14,549 | 800.00K |
| 413 | KZR | Kezar Life Sciences, Inc. | 54.55M | - | 53,393 | - |
| 414 | TIL | Instil Bio, Inc. | 54.46M | 0.37% | 23,751 | - |
| 415 | OSTX | OS Therapies Incorporated | 53.77M | - | 188,725 | - |
| 416 | NBY | NovaBay Pharmaceuticals, Inc. | 51.92M | 22.64% | 637,597 | 10.30M |
| 417 | RADX | Radiopharm Theranostics Limited | 51.41M | 1.85% | 24,166 | 10.86M |
| 418 | EDSA | Edesa Biotech, Inc. | 51.26M | 10.63% | 418,040 | - |
| 419 | MREO | Mereo BioPharma Group plc | 51.08M | -3.03% | 2,321,161 | 500.00K |
| 420 | MGX | Metagenomi Therapeutics, Inc. | 50.79M | 0.75% | 83,125 | 25.21M |
| 421 | INKT | MiNK Therapeutics, Inc. | 50.18M | 1.14% | 35,868 | - |
| 422 | ALGS | Aligos Therapeutics, Inc. | 49.32M | 2.97% | 39,566 | 2.19M |
| 423 | XLO | Xilio Therapeutics, Inc. | 49.21M | 1.06% | 25,998 | 43.77M |
| 424 | HOWL | Werewolf Therapeutics, Inc. | 49.08M | 5.38% | 402,829 | 1.14M |
| 425 | ATOS | Atossa Therapeutics, Inc. | 46.20M | 4.99% | 71,695 | - |
| 426 | LSTA | Lisata Therapeutics, Inc. | 45.34M | 0.20% | 15,337 | 170.00K |
| 427 | ESLA | Estrella Immunopharma, Inc. | 44.80M | - | 10,385 | - |
| 428 | IMMP | Immutep Limited | 44.79M | -2.30% | 284,416 | 5.28M |
| 429 | RLYB | Rallybio Corporation | 44.59M | 0.18% | 14,563 | 858.00K |
| 430 | RNXT | RenovoRx, Inc. | 44.15M | 1.03% | 130,079 | 1.12M |
| 431 | NTRB | Nutriband Inc. | 44.13M | 0.83% | 9,797 | 2.28M |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 43.66M | -3.79% | 87,318 | - |
| 433 | ATRA | Atara Biotherapeutics, Inc. | 40.81M | -3.48% | 46,931 | 120.77M |
| 434 | LITS | Lite Strategy, Inc. | 40.73M | - | 218,870 | - |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | 39.25M | -10.84% | 66,394 | - |
| 436 | CELU | Celularity Inc. | 38.35M | 1.53% | 12,934 | 40.58M |
| 437 | CRVO | CervoMed Inc. | 38.33M | 3.50% | 72,249 | 4.01M |
| 438 | NXTC | NextCure, Inc. | 38.17M | 1.80% | 10,783 | - |
| 439 | VERU | Veru Inc. | 36.76M | 0.88% | 32,409 | 16.89M |
| 440 | PDSB | PDS Biotechnology Corporation | 34.75M | 4.73% | 232,079 | - |
| 441 | RNTX | Rein Therapeutics Inc. | 33.93M | - | 155,082 | - |
| 442 | PTN | Palatin Technologies, Inc. | 33.64M | 3.02% | 16,526 | 8.96M |
| 443 | PLUR | Pluri Inc. | 33.37M | -0.90% | 4,515 | 1.34M |
| 444 | DYAI | Dyadic International, Inc. | 32.43M | 4.45% | 33,296 | 3.09M |
| 445 | INMB | INmune Bio Inc. | 32.17M | -1.63% | 323,249 | 50.00K |
| 446 | APLM | Apollomics, Inc. | 31.61M | -7.13% | 510 | 6.93M |
| 447 | EVAX | Evaxion A/S | 31.53M | -4.06% | 3,802 | 7.53M |
| 448 | LGVN | Longeveron Inc. | 31.33M | -4.46% | 1,195,301 | 1.20M |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 30.56M | -0.97% | 59,349 | 90.00K |
| 450 | BCTX | BriaCell Therapeutics Corp. | 29.39M | -0.97% | 112,130 | - |
| 451 | NRSN | NeuroSense Therapeutics Ltd. | 29.34M | 9.21% | 99,044 | - |
| 452 | HYPD | Hyperion DeFi, Inc. | 29.19M | -0.61% | 454,616 | 813.46K |
| 453 | KYNB | Kyntra Bio, Inc. | 28.37M | -1.27% | 11,549 | 6.44M |
| 454 | TVRD | Tvardi Therapeutics, Inc. | 28.33M | 0.67% | 63,366 | - |
| 455 | CVM | CEL-SCI Corporation | 28.08M | 1.17% | 18,144 | - |
| 456 | ABVC | ABVC BioPharma, Inc. | 26.93M | 0.93% | 54,645 | 797.92K |
| 457 | XCUR | Exicure, Inc. | 26.71M | 0.24% | 8,450 | 500.00K |
| 458 | SNTI | Senti Biosciences, Inc. | 26.67M | 2.07% | 85,993 | 22.00K |
| 459 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.57M | 2.45% | 20,877 | - |
| 460 | SER | Serina Therapeutics, Inc. | 26.11M | - | 409,587 | 130.00K |
| 461 | PASG | Passage Bio, Inc. | 25.92M | 4.14% | 17,530 | - |
| 462 | LEXX | Lexaria Bioscience Corp. | 25.88M | 20.08% | 668,357 | 522.00K |
| 463 | IGC | IGC Pharma, Inc. | 25.40M | -2.32% | 91,488 | 1.11M |
| 464 | DARE | Daré Bioscience, Inc. | 25.33M | -8.42% | 94,403 | 1.03M |
| 465 | BRNS | Barinthus Biotherapeutics plc | 24.51M | 11.09% | 19,131 | 14.97M |
| 466 | PSTV | Plus Therapeutics, Inc. | 24.43M | -8.60% | 612,634 | 5.21M |
| 467 | BOLD | Boundless Bio, Inc. | 24.20M | -4.42% | 268,574 | - |
| 468 | NEUP | Neuphoria Therapeutics Inc. | 23.77M | 7.04% | 62,916 | 14.99M |
| 469 | QNTM | Quantum BioPharma Ltd. | 23.46M | -9.75% | 442,998 | - |
| 470 | CYCN | Cyclerion Therapeutics, Inc. | 23.41M | -3.61% | 11,354,977 | 2.07M |
| 471 | SKYE | Skye Bioscience, Inc. | 23.30M | 4.98% | 212,070 | - |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 23.24M | -2.33% | 329,809 | 789.00K |
| 473 | OTLK | Outlook Therapeutics, Inc. | 22.91M | 4.29% | 1,460,161 | 205.70K |
| 474 | TPST | Tempest Therapeutics, Inc. | 22.81M | -1.85% | 71,337 | - |
| 475 | AEON | AEON Biopharma, Inc. | 22.49M | -9.16% | 97,988 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 22.01M | 0.76% | 94,234 | 3.55M |
| 477 | CRIS | Curis, Inc. | 21.98M | 3.17% | 422,885 | 9.44M |
| 478 | COCP | Cocrystal Pharma, Inc. | 20.81M | 48.04% | 137,317,987 | - |
| 479 | NNVC | NanoViricides, Inc. | 20.09M | -2.55% | 177,166 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 20.03M | -0.83% | 125,712 | 570.00K |
| 481 | PLRZ | Polyrizon Ltd. | 19.60M | -4.20% | 37,940 | - |
| 482 | JSPR | Jasper Therapeutics, Inc. | 19.25M | -14.00% | 891,070 | - |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 19.11M | 1.32% | 287,074 | 3.94M |
| 484 | ALLR | Allarity Therapeutics, Inc. | 18.65M | 2.65% | 55,112 | 320.00K |
| 485 | TVGN | Tevogen Bio Holdings Inc. | 18.57M | -0.45% | 17,955 | - |
| 486 | LTRN | Lantern Pharma Inc. | 18.16M | 14.08% | 1,301,789 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 17.78M | 3.48% | 315,058 | - |
| 488 | CUE | Cue Biopharma, Inc. | 17.57M | -11.20% | 1,445,244 | 27.47M |
| 489 | ICU | SeaStar Medical Holding Corporation | 17.21M | 21.07% | 423,330 | 1.23M |
| 490 | GNTA | Genenta Science S.p.A. | 16.64M | 1.85% | 36,348 | - |
| 491 | LPCN | Lipocine Inc. | 14.96M | -77.84% | 7,397,255 | 1.98M |
| 492 | HIND | Vyome Holdings, Inc. | 14.95M | -0.93% | 5,546 | 319.71K |
| 493 | PHIO | Phio Pharmaceuticals Corp. | 14.87M | -1.54% | 99,965 | - |
| 494 | INTS | Intensity Therapeutics, Inc. | 14.48M | 0.18% | 23,862 | - |
| 495 | GTBP | GT Biopharma, Inc. | 14.18M | 9.79% | 407,702 | - |
| 496 | INAB | IN8bio, Inc. | 14.18M | 2.86% | 19,051 | - |
| 497 | OSRH | OSR Holdings, Inc. | 14.11M | -6.29% | 903,925 | 2.91M |
| 498 | BCDA | BioCardia, Inc. | 13.13M | 3.45% | 93,975 | 3.00K |
| 499 | TRAW | Traws Pharma, Inc. | 13.11M | -1.20% | 86,134 | 2.85M |
| 500 | JUNS | Jupiter Neurosciences, Inc. | 12.69M | -2.90% | 42,227 | 21.80K |